The importance of patient-reported outcomes in clinical trials and strategies for future optimization
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Patient-reported outcomes (PROs) can be included in clinical trials as primary or secondary endpoints and are increasingly recognized by regulators, clinicians, and patients as valuable tools to collect patient-centered data. PROs provide unique information on the impact of a medical condition and its treatment from the patient's perspective; therefore, PROs can be included in clinical trials to ensure the impact of a trial intervention is comprehensively assessed. This review first discusses examples of how PRO endpoints have added value to clinical trial interpretation. Second, it describes the problems with current practices in designing, implementing, and reporting PRO studies, and how these problems may be addressed by complying with guidance for protocol development, selecting appropriate PRO measures to match clinically motivated PRO hypotheses, minimizing the rates of avoidable missing PRO data, analyzing and interpreting PRO data, and transparently reporting PRO findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The weaRAble-PRO study administered a selection of validated PRO measures for RA in complement to bespoke digital PRO assessments—that are validated in clinical trials”
From Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis (2024) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00583 · Cited by 7,363 · cited 2×
“It should be used in conjunction with the SPIRIT 2013 statement 32,33 when developing a research protocol for a trial with a primary or important secondary PRO endpoint.”
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251 · cited 2×
“It should be used in conjunction with the SPIRIT 2013 statement 32,33 when developing a research protocol for a trial with a primary or important secondary PRO endpoint.”
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000251 · Cited by 2,296
Tannock, I. F., Osoba, D., Stockler, M. R., Ernst, D. S., Neville, A. J., Moore, M. J., Armitage, G. R., Wilson, J. J., Venner, P. M., Coppin, C. M., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1756 · Cited by 1,580 · cited 2×
“21,22 The PRO endpoints led to regulatory approval of mitoxantrone for this indication and wide implementation in the clinic.”
InfluentialSelf-citationReporting of Patient-Reported Outcomes in Randomized Trials: The CONSORT PRO Extension
Calvert, M., Blazeby, J., Altman, D. G., Revicki, D. A., Moher, D., Brundage, M. D., & CONSORT PRO Group, F. T. (2013) · JAMA · doi:10.1001/jama.2013.879 · Cited by 1,386 · cited 2×
“This work informed the development of a CONSORT-PRO Extension (Consolidated Standards of Reporting Trials), which can be considered the minimum reporting items for PRO endpoints (primary or key secondary) in RCTs. 73 CONSORT-PRO consists of 14 items, five of which were newly developed PRO-specific reporting recommenda…”
Self-citationReducing waste from incomplete or unusable reports of biomedical research
Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., Michie, S., Moher, D., & Wager, E. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62228-x · Cited by 1,319 · cited 1×
“However, the issue of non-reporting of PROs is emerging and requires attention, as it is unethical to waste the funding, resources, and patients’ efforts expended in PRO data collection.(71)”
Cherny, N. I., Sullivan, R., Dafni, U., Kerst, J. M., Sobrero, A., Zielinski, C., de Vries, E. G. E., & Piccart, M. J. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv249 · Cited by 818 · cited 2×
“In oncology, for example, the American Society of Clinical Oncology (ASCO)(10) and European Society for Medical Oncology (ESMO)(11) have proposed standardized approaches to evaluate clinical trial results by using scores to evaluate the Magnitude of Clinical Benefit (ESMO MCB) or the Net Health Benefit (ASCO), which i…”
Calvert, M., Kyte, D., Mercieca-Bebber, R., Slade, A., Chan, A.-W., King, M. T., and the SPIRIT-PRO Group, Hunn, A., Bottomley, A., Regnault, A., et al. (2018) · JAMA · doi:10.1001/jama.2017.21903 · Cited by 814 · cited 5×
“A second review examined the PRO content of 26 protocols of Phase III international, ovarian cancer trials published between 2000 and 2016 against a list of PRO-specific items that would eventually inform the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)-PRO Extension.(29,30) Of the 26 tr…”
InfluentialSelf-citation
Research works printed but not linked: 2
- [15]Food and Drug Administration Ovarian Cancer Endpoints Workshop April 26, 2006, Meeting Summary 2006 Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/Developmen-tResources/CancerDrugs/ucm094598.pdf accessed 09 August 2016 https://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/ucm120657.pdf Accessed 14 August 2017.v
- [56]Mercieca-Bebber R Palmer MJ Brundage M Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review BMJ Open 2016 6 6 e010938 PMC4916640 27311907
Cited by
Items 501–600 of 660
REPORTING OF PATIENT-REPORTED OUTCOMES IN RCTS FOCUSED ON TINNITUS: A META STUDY
Bacani, R. C., Snider, K., Jacobsen, S. M., Ladd, C., Heigle, B., Kee, M. D., Hillman, C., Ottwell, R., Hartwell, M. L., & Vassar, M. B. (2022) · Journal of Hearing Science · doi:10.17430/jhs.2022.12.3.3
[Application of patient-reported-outcome in myelodysplastic syndromes].
Liu, L. L., & Xiao, Z. (2022) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2022.08.019
“[19] Mercieca-Bebber R, King MT, Calvert MJ, et al.”
Framroze, Z., Rinaldo, F. M., Lewis, E., Steels, J.-C., & Dickinson, H. A. (2023) · doi:10.2196/preprints.46416
miki, T., Samukawa, M., Higuchi, D., Kondo, Y., Watanabe, Y., Takebayashi, T., Ishida, T., kasahara, S., & Tohyama, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2594911/v1
Therapy Development for Spinocerebellar Ataxia: Rating Scales and Biomarkers
Lin, C., & Kuo, S. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24345-5_9
Patient-Reported Outcomes Can Serve as a Functional Substitute for Grip Strength
Cantu, C. A., Myhand, M. J., Hazime, A. A., Yedulla, N. R., & Day, C. S. (2023) · Journal of Wrist Surgery · doi:10.1055/s-0043-1772254 · Cited by 3
“11 This trend has given rise to numerous PRO measures.”
Can time to deterioration in patient-reported outcomes be a surrogate for overall survival?
Mazza, G. L. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad162
4-DOMAIN SPORTS PROM: TRADUÇÃO E ADAPTAÇÃO CULTURAL PARA A LÍNGUA PORTUGUESA
de Toledo, A. H. N., Ferreira, D. M., de Vasconcelos, R. A., Filho, M. F., Pedrinelli, A., & Piedade, S. R. (2023) · Revista Brasileira de Medicina do Esporte · doi:10.1590/1517-8692202430022022_0562p
Rosales, H. R., Gallo, L., Rae, C. S., Riff, K. W. Y. W., Pusic, A. L., & Klassen, A. F. (2023) · Facial Plastic Surgery & Aesthetic Medicine · doi:10.1089/fpsam.2023.0151
“13 Limitations There are several limitations to this study.”
Manoharan, D., Thompson, K. G., Gage, D., & Scott, J. F. (2023) · Archives of Dermatological Research · doi:10.1007/s00403-023-02738-8
Outcome measures for use in trials of paediatric otorrhoea: A systematic review
Heward, E., Dempsey, J. F., Molloy, J., Isba, R., Lunn, J., Ashcroft, D. M., Hay, A. D., Nichani, J., & Bruce, I. A. (2023) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2023.111820
Clinical severity measures and patient‐reported outcomes in atopic dermatitis
Sampogna, F., Dattolo, A., Cocuroccia, B., Moretta, G., Provini, A., Sordi, D., Fusari, R., Salcedo, N. M., & ABENI, D. D. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19753
Lovegrove, C., Sturkenboom, I. H. W. M., Smith, M. K., Marsden, J. F., & Bannigan, K. (2024) · doi:10.2196/preprints.56640
Outcome of Vital Pulp Treatment and Regenerative Endodontics
Cushley, S., Shimizu, E., Kobayashi, Y., & Nagendrababu, V. (2024) · Wiley eBooks · doi:10.1002/9781119930419.ch10
Demedis, J., Bingen, K. M., Cherven, B. O., Frederick, N. N., Freyer, D. R., Levine, J. M., Bhutada, J. S., Quinn, G. P., Bober, S. L., & DuVall, A. S. (2024) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2023.0115
Kramer, J., Wilens, T. E., Rao, V., Villa, R., & Yule, A. M. (2024) · JMIR Formative Research · doi:10.2196/52801
“PROMs can be self-administered and completed by patients on paper or electronically on a device or web-based platform [2].”
BackgroundBailey, J. R., Fonseca, E., Borsa, A., Hawryluk, E., Gubernick, S. I., de la Motte, A., Karantzoulis, S., Reaney, M. D., & Saretsky, T. L. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003482
“31,32 The Health Resources & Services Administration Ryan White HIV/AIDS Program also endorses using PROMs as a way to elevate patient care.”
Abolfazli, R., Nabavi, S. M., Azimi, A., Nahayati, M., Gharagozli, K., Torabi, H., Ghazaeian, M., Rezagholi, Z., & Samadzadeh, S. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108552
Reflections on the Optimal Use of eDiaries for Data Collection in Vaccine Clinical Trials (Preprint)Preprint
Nukala, U., Cho, S., A. S., Zhou, J., Steele, W. R., Whitaker, B. I., Chang, S. H., & Ezzeldin, H. (2024) · doi:10.2196/preprints.66971
Agussalim, A., Erawan, T., & Nugroho, H. S. W. (2024) · Journal of Pain Research · doi:10.2147/jpr.s498014
Use of Financial Hardship as a Metric for Assessing Financial Toxicity in Surgical Trauma Patients
Ehsan, A. N., Saha, S., Hathi, P., Vengadassalapathy, S., Sana, H., Ganesh, P., Huang, C.-C., Chauhan, S., Singhal, M., Weissman, J. S., et al. (2024) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000010761
Lee, J., Kim, S.-S., Lee, S.-I., Kim, T., Hong, S.-J., Lee, H., Lee, J., Park, Y.-W., Lee, S. W., Noh, J., et al. (2024) · Medicine Case Reports and Study Protocols · doi:10.1097/md9.0000000000000341
Downes, M., Kim, K. I., Custódio, M. G., Solev, I., Simoncini, T., & Qi, Y. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1008518 · Cited by 1
Chockalingam, M., Pearson, L., & Daly, O. (2025) · Journal of Hand Therapy · doi:10.1016/j.jht.2024.09.001
Development and content validity of the Glut1DS Movement Disorder Diary
Williams‐Hall, R., Bentley, S., Bradley, H., Arbuckle, R., Fromy, P., O’Mara, A., Brandabur, M. M., Bowden, A., & Blair, S. (2025) · Future Rare Diseases · doi:10.1080/23995270.2025.2466996
A Narrative View on Drug Development and Its Ethical Aspects
Klüglich, M. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009250
Periodontal esthetics perception and quality of life in patients with mucogingival problems
Karaaslan, F., & Esra, Ö. (2025) · Balkan Journal of Dental Medicine · doi:10.5937/bjdm2501047k
A Systematic Review of Surgical Techniques for the Repair of Capitellar Fractures
Memon, K., Awan, M., Alsadoun, L., Ahmad, S., Chan, S., Kalogrianitis, S., & Abro, A. A. (2025) · Cureus · doi:10.7759/cureus.81304
“Future research should also explore minimally invasive surgical techniques [21], which could offer benefits in terms of recovery time, soft tissue preservation, and cosmetic outcomes.”
Miedany, Y. M. E., Elgaafary, M., Bahlas, S. M., Hassan, W. A., Mahran, S., Miedany, A. E., & Elwakil, W. (2025) · Egyptian Rheumatology and Rehabilitation · doi:10.1186/s43166-025-00318-4
“Research wise, PROMs can also allow the incorporation of the patients’ perspective into variable research studies—electronic recording of the PROMs measures facilitate the inclusion of this information into big data longitudinal and cross-sectional observational research [29, 30].”
Shah, N. M., Apps, C., Amin, R., Kaltsakas, G., Hart, N., Murphy, P. B., & Rose, L. (2025) · ERJ Open Research · doi:10.1183/23120541.01007-2024 · Cited by 1
Thaçi, D., Gerdes, S., Schulze‐Koops, H., Allanore, Y., Kavanaugh, A., Both, C., Gattu, S., Hachaichi, S., & Matucci‐Cerinic, M. (2025) · Drugs in R&D · doi:10.1007/s40268-025-00507-8
“There are many examples in the literature demonstrating the importance of utilizing PROs to assess the clinical effectiveness of treatment [19], and how these data can support and enhance other clinical assessment indicators in patients with rheumatic diseases [15–17].”
Paul, M., BOSCH, R. F., Subin, B., Guth, A., Mueller, M., Seelinger, M., Riemann, S., & Aßmus, B. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15312
Dittrich, T., Weinert, L., & D’Souza, A. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101303 · Cited by 1
Report forms—Harm and quality of life
Kapoor, N., & Mehta, D. I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-821426-8.00017-0
Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management
Bollinger, A., Hersberger, K. E., Gianora, J., Urdieux, I. O., zu Schwabedissen, H. E. M., Rommers, N., Schwenkglenks, M. M., Stäuble, C. K., & Allemann, S. S. (2025) · Health Services Insights · doi:10.1177/11786329251356560
“22,51 In addition, chronic pain patients frequently experience drug changes, which can lead to uncertainty and frustration.”
Liu, T. F. D., Kazmi, F., Barry, C., Mishra, S. R., Dahal, P. K., Katyal, R., & Shrestha, N. (2025) · Research Square · doi:10.21203/rs.3.rs-7091849/v1
Al‐Beltagi, M., Saeed, N. K., Bediwy, A. S., & Elbeltagi, R. M. (2025) · World Journal of Methodology · doi:10.5662/wjm.v15.i4.102408
Yao, C. S., Lue, V., Stinnett, S. S., Luhmann, U. F. O., & Lad, E. M. (2025) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20250717-01
Patient-reported outcome measures used in clinical trials of an elbow orthosis: A scoping review
Ninow, H. T., Barman, A., Bhat, S. G., Wilson, G., & Kaufman, K. R. (2025) · Prosthetics and Orthotics International · doi:10.1097/pxr.0000000000000482
DeLorey, I., Bilker, W. B., Chudnovskaya, D., Conroy, A., McWilliams, T. L., Miller, C. A., Argoff, C. E., Barnett, I., Bell, R., Haythornthwaite, J. A., et al. (2025) · medRxiv · doi:10.1101/2025.08.13.25333581 · Cited by 1
“( Mercieca-Bebber et al., 2018; Moore et al., 1996) More recently, this has become an increasingly common analysis in studies of treatments for disease symptoms, particularly acute pain.”
Arensman, R. M., Haan, E. J. A., Terluin, B., Terwee, C. B., Wittink, H. M., & Kiers, H. (2025) · Advances in Patient-Reported Outcomes · doi:10.1016/j.apro.2025.100198
Patient-Reported Outcomes—The Missing Variable in Survival Prediction
Takayesu, J., & Gillespie, E. F. (2025) · JAMA Oncology · doi:10.1001/jamaoncol.2025.3167
Patient reported outcomes: practical and methodological considerations
Владиславовна, Х. Ю., & Suvorov, N. (2025) · Medical Technologies Assessment and Choice · doi:10.17116/medtech20254703122
Andersen, N. J., Bergeron, C., TURCOTTE, R. E., & Körner, A. (2025) · Journal of Surgical Oncology · doi:10.1002/jso.70101
Xiong, G., Shenouda, C., Metko, D., McMullen, E. P., Dumont, S., Croitoru, D. O., Alhusayen, R. O., & Piguet, V. (2025) · Clinical and Experimental Dermatology · doi:10.1093/ced/llaf447
Multi-federal agency actions to integrate patient-reported outcomes into cancer research and care
Smith, A. W., Dymek, C., Armstrong, T. S., Honig, B., Parker, A., McDevitt, S. K., Passero, V. A., Ketterer, A., & Bhatnagar, V. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf273
Nedeljković, S. S., Silinsky, J. D., Nagle, D. A., Lee, S. W., Ayad, S. S., Segura-Vasi, A. M., Fleshner, P. R., Choti, M. A., Wren, S. M., Jun Kosaka, B. P., et al. (2025) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000003990
“34,35 The trial was conducted across 36 sites, and patient/surgical characteristics appear representative of US patients undergoing elective bowel resection and are likely gener-alizable across multiple geographic and practice setting types.”
Guo, J. D., Hartzema, A. G., Cohen, J. B., Tunstall, N., & Gehchan, A. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-106180
Reinmuth, N., Couraud, S., Paz-Ares, L. G., Garassino, M. C., Baijal, S., Daniel, D. B., Garrido, P., Kato, T., Percent, I. J., Rittmeyer, A., et al. (2025) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2025.100929
“13,14 Here, to fully describe the experience of patients who received SG, we evaluated data on patient-reported health-related quality of life (HRQoL) and lung cancer-related symptoms from EVOKE-01.”
Kuwana, M., Watanabe, S., Takeuchi, T., Kaneko, Y., Kawaguchi, Y., Tanaka, Y., Yamaguchi, Y., Dobashi, H., Ishii, Y., Niiro, H., et al. (2025) · Modern Rheumatology · doi:10.1093/mr/roaf109
Imhof, S., Achermann, S., Rasenack, M., Hoogland, I. E., & Zörner, B. (2025) · Spinal Cord · doi:10.1038/s41393-025-01147-0
“The use of PROs has increased in both clinical research and regulatory settings, with growing recognition of their relevance as trial endpoints [7].”
Plata, I. C., Ortíz‐Rubio, A., Pérez-Gisbert, L., Torres‐Sánchez, I., Mateo, A. C., Valenza, M. C., & Ciuró, A. H. (2025) · Healthcare · doi:10.3390/healthcare13222948
Medical Cannabis and Epilepsy: The Evidence
Kaur, V., Deacon, H., Barnes, M. P., & Nutt, D. J. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0903 · Cited by 1
Ko, J. M., Kutty, S., Bulck, L. V., Jackson, J. L., Caruana, M., Fernandes, S. M., Mahadevan, V. S., Moons, P., & Cedars, A. M. (2025) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.012860
Kramer, F., Krauss, J., Pal, J., Batchelor, J., Yuksel, P., O´Sullivan, K., Stepien, M., & Bertha, A. (2025) · Digital Biomarkers · doi:10.1159/000549984
“They also help enrich the understanding on unique patient experiences and enable assessment of symptom bother from the patient’s perspective [21].”
Altinger, G., Sharma, S., Li, Q., Devaux, A., Darby, S., van Wyk, A., Jones, C. M. P., Maher, C. G., Traeger, A. C., Cullen, L., et al. (2025) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2025.112116
Greffin, K., Schmidt, S., van den Berg, N., Hoffmann, W., Ritter, O., Oeff, M., Schomerus, G., & Muehlan, H. (2021) · Figshare · doi:10.6084/m9.figshare.14913335
Rivera, S. C., McMullan, C., Jones, L., Kyte, D. G., Slade, A. L., & Calvert, M. (2020) · Figshare · doi:10.6084/m9.figshare.12607250
Self-citationMajercak, K. R., Perfetto, E. M., & Villalonga-Olives, E. (2022) · Figshare · doi:10.6084/m9.figshare.18864988
Puthucheary, Z., Gensichen, J. S., Cakiroglu, A. S., Cashmore, R., Edbrooke, L., Heintze, C., Neumann, K., Wollersheim, T., Denehy, L., & Schmidt, K. F. R. (2020) · Figshare · doi:10.6084/m9.figshare.13010808
Puthucheary, Z., Gensichen, J. S., Cakiroglu, A. S., Cashmore, R., Edbrooke, L., Heintze, C., Neumann, K., Wollersheim, T., Denehy, L., & Schmidt, K. F. R. (2020) · Figshare · doi:10.6084/m9.figshare.13010805
Greffin, K., Schmidt, S., van den Berg, N., Hoffmann, W., Ritter, O., Oeff, M., Schomerus, G., & Muehlan, H. (2021) · Figshare · doi:10.6084/m9.figshare.14913332
Antunes, A., Racha-Pacheco, R., Esteves, C., Tavares, A., Mendez, J., Pacheco, P., & Short, D. (2024) · Figshare · doi:10.6084/m9.figshare.26593307
Greffin, K., Schmidt, S., van den Berg, N., Hoffmann, W., Ritter, O., Oeff, M., Schomerus, G., & Muehlan, H. (2021) · Figshare · doi:10.6084/m9.figshare.14913329
Puthucheary, Z., Gensichen, J. S., Cakiroglu, A. S., Cashmore, R., Edbrooke, L., Heintze, C., Neumann, K., Wollersheim, T., Denehy, L., & Schmidt, K. F. R. (2020) · Figshare · doi:10.6084/m9.figshare.13010811
DeMuro, C., Mayorga, M. A., Ruiz‐Guiñazú, J., Trudel, G. C., Fehnel, S. E., McQuarrie, K., Chan, E. K. H., & Katz, E. G. (2024) · Figshare · doi:10.6084/m9.figshare.26564415
Müller, A. R., Luijten, M. A. J., Haverman, L., de Ranitz‐Greven, W. L., Janssens, P., Rietman, A. B., ten Hoopen, L. W., de Graaff, L. C. G., de Wit, M.-C., Jansen, A. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26609208
Dhaenens, B. A. E., van Dijk, S. A., Fertitta, L., Taal, W., Wolkenstein, P., & Oostenbrink, R. (2024) · Figshare · doi:10.6084/m9.figshare.25929234
Müller, A. R., Luijten, M. A. J., Haverman, L., de Ranitz‐Greven, W. L., Janssens, P., Rietman, A. B., ten Hoopen, L. W., de Graaff, L. C. G., de Wit, M.-C., Jansen, A. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26609211
Puthucheary, Z., Gensichen, J. S., Cakiroglu, A. S., Cashmore, R., Edbrooke, L., Heintze, C., Neumann, K., Wollersheim, T., Denehy, L., & Schmidt, K. F. R. (2020) · Figshare · doi:10.6084/m9.figshare.13010820
Therrien, F., Meehan, S. R., Weiss, C., Dine, J. L., Brown, T. M., & MacKenzie, E. M. (2022) · Figshare · doi:10.6084/m9.figshare.21321382
Verlis, K. M., McCaffery, K. J., Copp, T., Dodd, R. H., Laidsaar‐Powell, R., & Nickel, B. (2024) · Figshare · doi:10.6084/m9.figshare.26339948
Moss, M. C. L., Aggarwal, A., Qureshi, A., Taylor, B. P., Urbano, T. G., & Hemelrijck, M. V. (2021) · Figshare · doi:10.6084/m9.figshare.13585457
Rivera, S. C., McMullan, C., Jones, L., Kyte, D. G., Slade, A. L., & Calvert, M. (2020) · Figshare · doi:10.6084/m9.figshare.12607247
Self-citationRivera, S. C., McMullan, C., Jones, L., Kyte, D. G., Slade, A. L., & Calvert, M. (2020) · Figshare · doi:10.6084/m9.figshare.12607256
Self-citationMurea, M., Highland, B. R., Yang, W. Z., Dressler, E. V. M., & Russell, G. B. (2022) · Figshare · doi:10.6084/m9.figshare.21220406
Murea, M., Highland, B. R., Yang, W. Z., Dressler, E. V. M., & Russell, G. B. (2022) · Figshare · doi:10.6084/m9.figshare.21220409
Stewart, K. D., Matza, L. S., Patel, H. N., & Boye, K. S. (2023) · Figshare · doi:10.6084/m9.figshare.24098185
Rivera, S. C., McMullan, C., Jones, L., Kyte, D. G., Slade, A. L., & Calvert, M. (2020) · Figshare · doi:10.6084/m9.figshare.12607244
Self-citationBerry, L., Walter, J., Johnson, J. L., Alton, J., Powers, J., Llòria, X., Koulinska, I. N., McGee, M., & Laney, D. (2024) · Figshare · doi:10.6084/m9.figshare.25591303
Pape, L. M., Adriaanse, M. C., Kol, J., van Straten, A., & van Meijel, B. (2022) · Figshare · doi:10.6084/m9.figshare.19596228
Rodrigues, A., Abi‐Nader, S., Durand, R., Rompre, P. H., Janati, A. I., Atsu, S., Morris, M., & Emami, E. (2024) · Figshare · doi:10.6084/m9.figshare.25951933
Rivera, S. C., McMullan, C., Jones, L., Kyte, D. G., Slade, A. L., & Calvert, M. (2020) · Figshare · doi:10.6084/m9.figshare.12607253
Self-citationBerry, L., Walter, J., Johnson, J. L., Alton, J., Powers, J., Llòria, X., Koulinska, I. N., McGee, M., & Laney, D. (2024) · Figshare · doi:10.6084/m9.figshare.25591474
Majercak, K. R., Perfetto, E. M., & Villalonga-Olives, E. (2022) · Figshare · doi:10.6084/m9.figshare.18864985
Rodrigues, A., Abi‐Nader, S., Durand, R., Rompre, P. H., Janati, A. I., Atsu, S., Morris, M., & Emami, E. (2024) · Figshare · doi:10.6084/m9.figshare.25951810
Puthucheary, Z., Gensichen, J. S., Cakiroglu, A. S., Cashmore, R., Edbrooke, L., Heintze, C., Neumann, K., Wollersheim, T., Denehy, L., & Schmidt, K. F. R. (2020) · Figshare · doi:10.6084/m9.figshare.13010817
Müller, A. R., Luijten, M. A. J., Haverman, L., de Ranitz‐Greven, W. L., Janssens, P., Rietman, A. B., ten Hoopen, L. W., de Graaff, L. C. G., de Wit, M.-C., Jansen, A. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26609205
Chan, E. K. H., Williams, V. S. L., DeMuro, C., Fehnel, S. E., Slagle, A. F., Stoddard, J. J., SADOFF, J. C., Mayorga, M. A., Lewis, S., Yarr, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590095
Metadata
- Authors
- Mercieca-Bebber, R., King, M. T., Calvert, M. J., Stockler, M. R., & Friedlander, M.
- Affiliations
- The University of Sydney (AU)
- National Institute for Health and Care Research (GB)
- Corresponding author
- Friedlander, Michael
- Venue
- Patient Related Outcome Measures
- Publisher
- Informa UK Limited
- Published
- 2018-11
- Volume
- Volume 9
- Pages
- 353-367
- ISSN
- 1179-271X (ISSN-L)
- PMC
- PMC6219423
- OpenAlex
- W2899320385
- Cited by
- 659
- References
- 73
- Citations by year
- 2026: 77 · 2025: 129 · 2024: 138 · 2023: 88 · 2022: 85 · 2021: 75 · 2020: 54 · 2019: 12
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Patient Related Outcome Measures (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- University Hospitals Birmingham NHS Foundation Trust
- Australian Government
- National Institute for Health and Care Research
- University of Birmingham
- Cancer Australia
- Surgical Reconstruction and Microbiology Research Centre
- National Health and Medical Research Council
- Birmingham Biomedical Research Centre
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- patient-reported outcomes, clinical trial endpoints, missing data, protocol design, patient-centered outcomes, regulatory guidelines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.